Prospective data from the Women’s Health Initiative study, however, indicate that overweight women who are metabolically healthy and have normal insulin sensitivity do not have an increased risk for breast cancer, whereas normal weight or obese women with insulin resistance are at risk, suggesting that insulin resistance, rather than obesity per se, is the driving factor17. The gene discussed is INS; the disease is Insulin resistance.